Feasibility of IV Tc-99m-tilmanocept for Imaging of M2-like TAMs in Metastatic Melanoma
Clinical trial NCT04663126 · TERMINATED
Trial details
- NCT number
- NCT04663126
- Sponsor
- John O. Prior
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-01
- Primary completion
- 2023-01-08
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.